Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHE NYSE:DGX NYSE:DVA NYSE:LH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$450.83+1.7%$487.07$408.42▼$623.60$6.46B0.46187,739 shs158,732 shsDGXQuest Diagnostics$178.98+0.2%$174.48$146.17▼$182.38$19.98B0.461.33 million shs928,470 shsDVADaVita$134.60+1.9%$139.80$126.07▼$179.60$9.44B1.09921,474 shs614,912 shsLHLabcorp$272.52+1.2%$258.82$209.38▼$283.47$22.38B0.78758,666 shs532,056 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed+2.30%+3.10%-3.76%-20.37%-22.89%DGXQuest Diagnostics+0.19%+3.04%+6.32%+3.68%+18.75%DVADaVita+2.22%-6.31%-7.27%-5.72%-8.03%LHLabcorp+0.54%+2.19%+7.99%+11.03%+20.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHEChemed4.9912 of 5 stars3.45.03.34.92.93.32.5DGXQuest Diagnostics4.8316 of 5 stars1.35.04.24.73.52.52.5DVADaVita4.427 of 5 stars2.02.00.04.52.12.53.8LHLabcorp4.737 of 5 stars2.34.02.54.23.52.51.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEChemed 2.75Moderate Buy$579.7528.60% UpsideDGXQuest Diagnostics 2.67Moderate Buy$186.003.92% UpsideDVADaVita 2.00Hold$164.0021.84% UpsideLHLabcorp 2.62Moderate Buy$289.586.26% UpsideCurrent Analyst Ratings BreakdownLatest LH, DGX, DVA, and CHE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025DVADaVitaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$148.008/7/2025DVADaVitaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$169.00 ➝ $160.007/31/2025CHEChemedRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$640.00 ➝ $589.007/31/2025CHEChemedOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$650.00 ➝ $580.007/25/2025CHEChemedJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageHold$500.007/25/2025LHLabcorpUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$282.00 ➝ $305.007/25/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$290.00 ➝ $310.007/25/2025LHLabcorpEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$285.00 ➝ $300.007/25/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$283.00 ➝ $306.007/25/2025LHLabcorpRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$290.00 ➝ $302.007/23/2025DGXQuest DiagnosticsEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$185.00(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEChemed$2.43B2.70$26.15 per share17.24$82.25 per share5.48DGXQuest Diagnostics$9.87B2.03$13.53 per share13.23$64.97 per share2.75DVADaVita$12.82B0.75$19.51 per share6.90($1.51) per share-89.14LHLabcorp$13.01B1.74$22.67 per share12.02$101.96 per share2.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEChemed$302M$19.4523.1819.352.4411.56%25.83%17.77%N/ADGXQuest Diagnostics$871M$8.3521.4317.062.379.01%15.24%6.64%10/28/2025 (Estimated)DVADaVita$936.34M$10.1713.2410.590.956.35%369.39%4.62%N/ALHLabcorp$746M$9.0630.0815.541.725.66%15.45%7.02%10/23/2025 (Estimated)Latest LH, DGX, DVA, and CHE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025DVADaVita$2.70$2.95+$0.25$2.58$3.36 billion$3.38 billion7/29/2025Q2 2025CHEChemed$6.02$4.27-$1.75$3.57$650.60 million$618.80 million7/24/2025Q2 2025LHLabcorp$4.14$4.35+$0.21$2.84$3.49 billion$3.53 billion7/22/2025Q2 2025DGXQuest Diagnostics$2.57$2.62+$0.05$2.47$2.73 billion$2.76 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEChemed$2.400.53%N/A12.34%16 YearsDGXQuest Diagnostics$3.201.79%N/A38.32%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.881.06%N/A31.79%N/ALatest LH, DGX, DVA, and CHE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/13/2025DGXQuest Diagnosticsquarterly$0.801.79%10/3/202510/20/20257/10/2025LHLabcorpquarterly$0.721.11%8/28/20259/11/20258/4/2025CHEChemedquarterly$0.600.6%8/11/20258/11/20258/29/20255/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/20255/20/2025CHEChemedquarterly$0.500.3%5/29/20255/29/20256/17/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEChemedN/A1.861.83DGXQuest Diagnostics0.711.090.99DVADaVita23.181.391.34LHLabcorp0.611.501.32Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEChemed95.85%DGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%Insider OwnershipCompanyInsider OwnershipCHEChemed3.29%DGXQuest Diagnostics8.16%DVADaVita1.50%LHLabcorp0.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHEChemed15,69514.57 million14.09 millionOptionableDGXQuest Diagnostics56,000111.82 million102.70 millionOptionableDVADaVita76,00071.50 million70.43 millionOptionableLHLabcorp70,00083.10 million82.40 millionOptionableLH, DGX, DVA, and CHE HeadlinesRecent News About These Companies1 Mooning Stock Worth Investigating and 2 Facing ChallengesAugust 13 at 9:01 AM | msn.comLabcorp Holdings Inc. (NYSE:LH) Shares Bought by Westpac Banking CorpAugust 13 at 6:46 AM | marketbeat.comInvesco Ltd. Purchases 318,865 Shares of Labcorp Holdings Inc. (NYSE:LH)August 13 at 4:49 AM | marketbeat.comMizuho Securities USA LLC Sells 1,249 Shares of Labcorp Holdings Inc. (NYSE:LH)August 13 at 4:49 AM | marketbeat.com1 Safe-and-Steady Stock to Target This Week and 2 We Find RiskyAugust 12 at 5:58 PM | msn.comCCM Investment Group LLC Takes Position in Labcorp Holdings Inc. (NYSE:LH)August 12 at 6:24 AM | marketbeat.comLabcorp Holdings Inc. (NYSE:LH) Shares Purchased by Forsta AP FondenAugust 12 at 4:53 AM | marketbeat.comLabcorp Holdings Inc. (NYSE:LH) Shares Sold by Swiss National BankAugust 12 at 4:34 AM | marketbeat.comDeutsche Bank AG Sells 21,687 Shares of Labcorp Holdings Inc. (NYSE:LH)August 12 at 4:14 AM | marketbeat.comCharles Schwab Investment Management Inc. Has $147.74 Million Stock Position in Labcorp Holdings Inc. (NYSE:LH)August 12 at 4:13 AM | marketbeat.comLabcorp Holdings Inc. (NYSE:LH) Shares Sold by Barnett & Company Inc.August 11 at 7:42 AM | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Acquires 13,620 Shares of Labcorp Holdings Inc. (NYSE:LH)August 11 at 6:21 AM | marketbeat.comASR Vermogensbeheer N.V. Invests $650,000 in Labcorp Holdings Inc. (NYSE:LH)August 11 at 6:03 AM | marketbeat.comLabcorp Holdings Inc. (NYSE:LH) Shares Purchased by Vanguard Group Inc.August 11 at 5:55 AM | marketbeat.comStatutory Profit Doesn't Reflect How Good Labcorp Holdings' (NYSE:LH) Earnings AreAugust 9, 2025 | finance.yahoo.comLabcorp Holdings Inc. (NYSE:LH) Stake Decreased by LPL Financial LLCAugust 9, 2025 | marketbeat.comJensen Investment Management Inc. Sells 8,070 Shares of Labcorp Holdings Inc. (NYSE:LH)August 7, 2025 | marketbeat.comAXS Investments LLC Grows Position in Labcorp Holdings Inc. (NYSE:LH)August 7, 2025 | marketbeat.comPNC Financial Services Group Inc. Sells 1,791 Shares of Labcorp Holdings Inc. (NYSE:LH)August 7, 2025 | marketbeat.comBank of Nova Scotia Sells 17,712 Shares of Labcorp Holdings Inc. (NYSE:LH)August 7, 2025 | marketbeat.comStocks Generating Improved Relative Strength: Labcorp HoldingsAugust 6, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAMD’s Results Sparked a Sell-Off—But That’s Your Buy SignalBy Thomas Hughes | August 6, 2025Tesla Teams With Samsung—Will Other Chipmakers Follow?By Gabriel Osorio-Mazilli | August 1, 2025The Market Rally Is Gaining Momentum—Don’t Get Left BehindBy Thomas Hughes | July 17, 2025A New $70 Billion AI Investment Could Push Taiwan Semiconductor By Gabriel Osorio-Mazilli | July 17, 2025AMD Paves Path for Market Share Gains: Stock Rally Has Just BegunBy Thomas Hughes | August 12, 2025LH, DGX, DVA, and CHE Company DescriptionsChemed NYSE:CHE$450.83 +7.69 (+1.74%) Closing price 03:59 PM EasternExtended Trading$450.66 -0.18 (-0.04%) As of 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Quest Diagnostics NYSE:DGX$178.98 +0.30 (+0.17%) Closing price 03:59 PM EasternExtended Trading$175.50 -3.48 (-1.94%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$134.60 +2.52 (+1.91%) Closing price 03:59 PM EasternExtended Trading$134.03 -0.57 (-0.43%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$272.52 +3.21 (+1.19%) Closing price 03:59 PM EasternExtended Trading$259.32 -13.20 (-4.84%) As of 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CAVA’s Honeymoon Ends With a 16% Stock Drop Rigetti Stock: A Long-Term Quantum Play Facing Short-Term Tests 5 Stocks Insiders Are Selling That Analysts Say Buy CoreWeave Pulls Back Into a Screaming Buy Amazon’s Bears Have Raised the White Flag—Get Excited Rocket Lab Scores Analyst Upgrades, Finalizes Geost Takeover Why BigBear.ai Stock's Dip on Earnings Can Be an Opportunity Catalysts Align: Archer Beats Estimates, Delivers Aircraft to UAE Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access